Chafic Y. Karam

Neurology

3400 Civic Center Boulevard
South Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 111 publications

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: Neurology

Published: June 16, 2026

Vasculitic neuropathy: clinical features, diagnostic approach, and neurological outcomes in a single-center cohort.

Vasculitic neuropathy: clinical features, diagnostic approach, and neurological outcomes in a single-center cohort.

Journal: Frontiers in neurology

Published: May 20, 2026

Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.

Polyneuropathy in p.V142I hereditary transthyretin amyloidosis: Diagnostic challenges and clinical considerations.

Journal: Journal of the neurological sciences

Published: May 19, 2026

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Journal: Journal of the neurological sciences

Published: May 13, 2026

A Practical Guide to Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

A Practical Guide to Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: Neurology and therapy

Published: March 12, 2026

Neuralgic Amyotrophy Following B-Cell Maturation Antigen-Directed CAR-T Therapy.

Neuralgic Amyotrophy Following B-Cell Maturation Antigen-Directed CAR-T Therapy.

Journal: Muscle & nerve

Published: February 20, 2026

Early-Onset Wild-Type Transthyretin Amyloidosis Polyneuropathy.

Early-Onset Wild-Type Transthyretin Amyloidosis Polyneuropathy.

Journal: Muscle & nerve

Published: December 22, 2025

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Journal: Journal of the neurological sciences

Published: December 15, 2025

Prevalence and attribution of polyneuropathy in p.V142I (V122I) hereditary transthyretin amyloidosis.

Prevalence and attribution of polyneuropathy in p.V142I (V122I) hereditary transthyretin amyloidosis.

Journal: Journal of the neurological sciences

Published: November 12, 2025

Acquired and Genetic Amyloid Neuropathies.

Acquired and Genetic Amyloid Neuropathies.

Journal: Neurologic clinics

Published: October 29, 2025

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.

Journal: Nature medicine

Published: October 27, 2025

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States.

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States.

Journal: Frontiers in neurology

Published: October 17, 2025

Showing 1-12 of 111

Last Updated: 09/26/2026